Safety Study of Preoperative Sunitinib and Radiation in Soft Tissue Sarcoma

NCT01498835 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

OTHER

Sponsor class

Conditions

Soft Tissue Sarcoma

Interventions

DRUG: Sunitinib

Sponsor

Heidelberg University

Collaborators

[object Object]